Lauro Wichert-Ana Selected Research

Seizures (Absence Seizure)

11/2017	Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects.
12/2013	Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study.
1/2013	Cognitive and surgical outcome in mesial temporal lobe epilepsy associated with hippocampal sclerosis plus neurocysticercosis: a cohort study.
2/2011	Utility of ictal single photon emission computed tomography in mesial temporal lobe epilepsy with hippocampal atrophy: a randomized trial.
6/2008	Ictal technetium-99 m ethyl cysteinate dimer single-photon emission tomographic findings in epileptic patients with polymicrogyria syndromes: a subtraction of ictal-interictal SPECT coregistered to MRI study.
1/2008	Is dystonic posturing during temporal lobe epileptic seizures the expression of an endogenous anticonvulsant system?
3/2007	Outcome of hemispheric surgeries for refractory epilepsy in pediatric patients.
3/2006	Pontine activation during focal status epilepticus secondary to hamartoma of the floor of the fourth ventricle.
7/2005	Surgically amenable epilepsies in children and adolescents: clinical, imaging, electrophysiological, and post-surgical outcome data.
7/2004	Surgical treatment for mesial temporal lobe epilepsy in the presence of massive calcified neurocysticercosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lauro Wichert-Ana Research Topics

Disease

11	Seizures (Absence Seizure) 11/2017 - 03/2004
5	Epilepsy (Aura) 01/2020 - 07/2004
5	Hippocampal Sclerosis 10/2015 - 05/2006
4	Temporal Lobe Epilepsy 10/2015 - 05/2006
2	Neurocysticercosis 10/2015 - 01/2013
2	Schizophrenia (Dementia Praecox) 02/2015 - 04/2010
1	Encephalitis (Encephalitis, Rasmussen) 03/2023
1	Neuralgia (Stump Neuralgia) 01/2023
1	Low Back Pain (Lumbago) 01/2023
1	Aortitis 01/2023
1	Pain (Aches) 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2022
1	Parkinson Disease (Parkinson's Disease) 09/2022
1	Duodenogastric Reflux 01/2022
1	Gastroesophageal Reflux (GERD) 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Joint Diseases (Joint Disease) 01/2021
1	Meningoencephalitis 01/2021
1	Chagas Cardiomyopathy 10/2019
1	Left Ventricular Dysfunction 10/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017
1	Neurolymphomatosis 01/2017
1	Clinical Deterioration 02/2015
1	Depressive Disorder (Melancholia) 01/2015
1	Mood Disorders (Mood Disorder) 01/2015
1	Mania (Manias) 01/2015
1	Cognitive Dysfunction 01/2013
1	Social Phobia 01/2011
1	Sudden Unexpected Death in Epilepsy 08/2010
1	Polymicrogyria 06/2008
1	Down Syndrome (Down's Syndrome) 05/2006
1	Epileptic Syndromes 05/2006
1	Hamartoma 03/2006
1	Status Epilepticus (Complex Partial Status Epilepticus) 03/2006
1	Hyperammonemia 06/2005
1	Cysticercosis 07/2004

Drug/Important Bio-Agent (IBA)

4	Anticonvulsants (Antiepileptic Drugs)IBA 12/2013 - 07/2005
3	N,N'- bis((2- chloroethyl)nitrosocarbamoyl)cystamine (CNCC)IBA 10/2015 - 01/2013
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2023 - 01/2017
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 11/2017 - 12/2013
2	Minocycline (Cyclops)FDA LinkGeneric 02/2015 - 04/2010
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2015 - 01/2011
2	Valine (L-Valine)FDA Link 02/2014 - 05/2006
2	Codon (Codons)IBA 02/2014 - 05/2006
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2023
1	Dopamine (Intropin)FDA LinkGeneric 12/2022
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 09/2022
1	A-factor (Streptomyces)IBA 01/2022
1	Yttrium-90IBA 01/2021
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2021
1	Fluconazole (Zonal)FDA LinkGeneric 01/2021
1	adriamycin-14-valerate (AD 48)IBA 01/2020
1	Dipyridamole (Persantine)FDA LinkGeneric 10/2019
1	GadoliniumIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2015
1	Tetracycline (Achromycin)FDA LinkGeneric 02/2015
1	Neuroprotective AgentsIBA 02/2015
1	Hallucinogens (Psychedelics)IBA 01/2015
1	Antidepressive Agents (Antidepressants)IBA 01/2015
1	CannabidiolIBA 01/2011
1	Technetium-99IBA 06/2008
1	ethyl cysteinate dimerIBA 06/2008
1	Prion ProteinsIBA 05/2006
1	Methionine (L-Methionine)FDA Link 05/2006
1	Valproic Acid (Depakote)FDA LinkGeneric 06/2005
1	ImmunosorbentsIBA 07/2004
1	EnzymesIBA 07/2004
1	Antipsychotic Agents (Antipsychotics)IBA 03/2004

Therapy/Procedure

5	Therapeutics 12/2013 - 07/2004
1	Aftercare (After-Treatment) 01/2023
1	Gastrectomy 01/2022
1	Length of Stay 02/2011
1	Hemispherectomy 03/2007